These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1551 related articles for article (PubMed ID: 26111795)

  • 21. Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma.
    Xu L; Chen Y; Mayakonda A; Koh L; Chong YK; Buckley DL; Sandanaraj E; Lim SW; Lin RY; Ke XY; Huang ML; Chen J; Sun W; Wang LZ; Goh BC; Dinh HQ; Kappei D; Winter GE; Ding LW; Ang BT; Berman BP; Bradner JE; Tang C; Koeffler HP
    Proc Natl Acad Sci U S A; 2018 May; 115(22):E5086-E5095. PubMed ID: 29764999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
    Tan SK; Pastori C; Penas C; Komotar RJ; Ivan ME; Wahlestedt C; Ayad NG
    Mol Cancer; 2018 Mar; 17(1):74. PubMed ID: 29558959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
    Zhang K; Li Q; Kang X; Wang Y; Wang S
    Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines.
    Liu Y; Xu N; Liu B; Huang Y; Zeng H; Yang Z; He Z; Guo H
    Oncotarget; 2016 Jul; 7(28):43835-43851. PubMed ID: 27270310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models.
    Berenguer-Daizé C; Astorgues-Xerri L; Odore E; Cayol M; Cvitkovic E; Noel K; Bekradda M; MacKenzie S; Rezai K; Lokiec F; Riveiro ME; Ouafik L
    Int J Cancer; 2016 Nov; 139(9):2047-55. PubMed ID: 27388964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1.
    Chen H; Hou G; Yang J; Chen W; Guo L; Mao Q; Ge J; Zhang X
    J Cell Mol Med; 2020 Jun; 24(11):6070-6082. PubMed ID: 32329150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis.
    Han L; Zhang K; Shi Z; Zhang J; Zhu J; Zhu S; Zhang A; Jia Z; Wang G; Yu S; Pu P; Dong L; Kang C
    Int J Oncol; 2012 Jun; 40(6):2004-12. PubMed ID: 22446686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non‑coding RNA Unigene56159 promotes glioblastoma multiforme cell proliferation and invasion through negatively regulating microRNA‑194‑5p.
    Jiang G; Dong H; Dong Y; Yang X
    Mol Med Rep; 2020 Feb; 21(2):768-776. PubMed ID: 31789416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.
    Boehm D; Calvanese V; Dar RD; Xing S; Schroeder S; Martins L; Aull K; Li PC; Planelles V; Bradner JE; Zhou MM; Siliciano RF; Weinberger L; Verdin E; Ott M
    Cell Cycle; 2013 Feb; 12(3):452-62. PubMed ID: 23255218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transcript ENST00000444125 of lncRNA LINC01503 promotes cancer stem cell properties of glioblastoma cells via reducing FBXW1 mediated GLI2 degradation.
    Wei P; Jiang J; Xiao M; Zeng M; Liu X; Zhao B; Chen F
    Exp Cell Res; 2022 Mar; 412(1):113009. PubMed ID: 34990616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repression of PDK1- and LncRNA HOTAIR-Mediated EZH2 Gene Expression Contributes to the Enhancement of Atractylenolide 1 and Erlotinib in the Inhibition of Human Lung Cancer Cells.
    Xiao Q; Zheng F; Tang Q; Wu JJ; Xie J; Huang HD; Yang XB; Hann SS
    Cell Physiol Biochem; 2018; 49(4):1615-1632. PubMed ID: 30223276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells.
    Hishiki K; Akiyama M; Kanegae Y; Ozaki K; Ohta M; Tsuchitani E; Kaito K; Yamada H
    Leuk Res; 2018 Nov; 74():57-63. PubMed ID: 30300821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRD4 bimodal binding at promoters and drug-induced displacement at Pol II pause sites associates with I-BET sensitivity.
    Khoueiry P; Ward Gahlawat A; Petretich M; Michon AM; Simola D; Lam E; Furlong EE; Benes V; Dawson MA; Prinjha RK; Drewes G; Grandi P
    Epigenetics Chromatin; 2019 Jul; 12(1):39. PubMed ID: 31266503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Potential Roles of Long Noncoding RNAs (lncRNA) in Glioblastoma Development.
    Liu S; Mitra R; Zhao MM; Fan W; Eischen CM; Yin F; Zhao Z
    Mol Cancer Ther; 2016 Dec; 15(12):2977-2986. PubMed ID: 27784795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme.
    Janaki Ramaiah M; Divyapriya K; Kartik Kumar S; Rajesh YBRD
    Gene; 2020 Jan; 723():144126. PubMed ID: 31589963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HOXB-AS1 accelerates the tumorigenesis of glioblastoma via modulation of HOBX2 and HOBX3 at transcriptional and posttranscriptional levels.
    Bi Y; Mao Y; Su Z; Du J; Ye L; Xu F
    J Cell Physiol; 2021 Jan; 236(1):93-106. PubMed ID: 33459377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis.
    Xiong C; Masucci MV; Zhou X; Liu N; Zang X; Tolbert E; Zhao TC; Zhuang S
    Oncotarget; 2016 Oct; 7(43):69291-69308. PubMed ID: 27732564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner.
    Zhang K; Sun X; Zhou X; Han L; Chen L; Shi Z; Zhang A; Ye M; Wang Q; Liu C; Wei J; Ren Y; Yang J; Zhang J; Pu P; Li M; Kang C
    Oncotarget; 2015 Jan; 6(1):537-46. PubMed ID: 25428914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma.
    Li Y; Wang Z; Wang Y; Zhao Z; Zhang J; Lu J; Xu J; Li X
    Oncotarget; 2016 Jul; 7(29):45027-45041. PubMed ID: 26943771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.
    Shu S; Lin CY; He HH; Witwicki RM; Tabassum DP; Roberts JM; Janiszewska M; Huh SJ; Liang Y; Ryan J; Doherty E; Mohammed H; Guo H; Stover DG; Ekram MB; Brown J; D'Santos C; Krop IE; Dillon D; McKeown M; Ott C; Qi J; Ni M; Rao PK; Duarte M; Wu SY; Chiang CM; Anders L; Young RA; Winer E; Letai A; Barry WT; Carroll JS; Long H; Brown M; Liu XS; Meyer CA; Bradner JE; Polyak K
    Nature; 2016 Jan; 529(7586):413-417. PubMed ID: 26735014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 78.